MOG antibody-associated disease presenting with tumefactive lesions and closed-ring enhancement

Hegen H, Reindl M (2020) Recent developments in MOG-IgG associated neurological disorders. Ther Adv Neurol Disord 13:1756286420945135. https://doi.org/10.1177/1756286420945135

Deneve M, Biotti D, Patsoura S et al (2019) MRI features of demyelinating disease associated with anti-MOG antibodies in adults. J Neuroradiol 46(5):312–318. https://doi.org/10.1016/j.neurad.2019.06.001

Jurynczyk M, Geraldes R, Probert F et al (2017) Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain 140(3):617–627. https://doi.org/10.1093/brain/aww350

Hardy TA (2019) Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome. Curr Opin Neurol 32(3):467–474. https://doi.org/10.1097/WCO.0000000000000683

Neuroimmunology Group of Neurology Branch of Chinese Medical Association, Neuroimmunology Committee of Chinese Society for Immunology, Immunology Society of Chinese Stroke Association (2017) Chinese guidelines for the diagnosis and management of tumefactive demyelinating lesions of central nervous system. Chin Med J (Engl) 130(15):1838–1850. https://doi.org/10.4103/0366-6999.211547

Masdeu JC, Quinto C, Olivera C et al (2000) Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 54(7):1427–1433. https://doi.org/10.1212/wnl.54.7.1427